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Abstract
More than 40 genetic susceptibility loci have been reported for type 2 diabetes (T2D). Recently, the combined effect of
genetic variants has been investigated by calculating a genetic risk score. We evaluated 36 genome-wide association study
(GWAS) identified SNPs in 2,679 T2D cases and 3322 controls in middle-age Han Chinese. Fourteen SNPs were significantly
associated with T2D in analysis adjusted for age, sex and BMI. We calculated two genetic risk scores (GRS) (GRS1 with all the
36 SNPs and GRS2 with the 14 SNPs significantly associated with T2D). The odds ratio for T2D with each GRS point (per risk
allele) was 1.08 (95% CI: 1.06–1.09) for GRS1 and 1.15 (95% CI: 1.13–1.18) for GRS2. The OR for quintiles were 1.00, 1.26, 1.69,
1.95 and 2.18 (P,0.0001) for GRS1 and 1.00, 1.33, 1.60, 2.03 and 2.80 (P,0.001) for GRS2. Participants in the higher tertile of
GRS1 and the higher BMI category had a higher risk of T2D compared to those on the lower tertiles of the GRS1 and of BMI
(OR= 11.08; 95% CI: 7.39–16.62). We found similar results when we investigated joint effects between GRS1 and WHR
terciles and exercise participation. We finally investigated the joint effect between tertiles of GRSs and a composite high risk
score (no exercise participation and high BMI and WHR) on T2D risk. We found that compared to participants with low GRS1
and no high risk factors for T2D, those with high GRS1 and three high risk factors had a higher risk of T2D (OR= 13.06; 95%
CI: 8.65–19.72) but the interaction factor was of marginal significance. The association was accentuated when we repeated
analysis with the GRS2. In conclusion we found an association between GRS and lifestyle factors, alone and in combination,
contributed to the risk of and T2D among middle age Chinese.
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Introduction
Type 2 diabetes (T2D) is a complex disease affecting more
than a billion people worldwide. Over the last two decades,
China, like many other Asian countries, has experienced
a dramatic increase in T2D incidence. Both genetic and
environmental factors contribute to the development of T2D.
Identifying genetic factors that contribute to T2D and their
interactions with environmental factors can lead to prevention
and lowering incidence of disease.
Through genome-wide association studies (GWAS), several
genetic susceptibility loci have been reported for T2D [1–8].
Most of the reported genetic variants have small to moderate
effects and account for only a small proportion of the
heritability of T2D. Some data is available on the joint effects
of common genetic variants on the risk of T2D [9–14].
However, most of these studies have not taken into consider-
ation interactions between genetic risk and environmental
factors. Looking at the joint effect between genetic risk and
lifestyle factors show a large effect size on associations with T2D
might help to identify high risk populations for intervention and
to elucidate the biology behind the associations between genes
and T2D.
In this report, we evaluated the association between reported
SNP from genome-wide association study (GWAS) with T2D
using data from a GWAS study of T2D of middle age women
and from a nested case control study from two population based
cohorts of middle age men and women living in urban
Shanghai, China and calculated genetic risk scores (GRSs) with
T2D susceptibility markers. We also looked at joint associations
between genetic risk score tertiles with tertiles of body mass
index (BMI), waist to hip ratio (WHR) and exercise participa-
tion and with a composite lifestyle high risk score including high
BMI, high WHR and no exercise participation.
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Methods
Ethics Statement
The study protocols were approved by the Institutional Review
Boards of Vanderbilt University and the Shanghai Cancer
Institute, and all participants provided written, informed consent.
Study Design and Population
Participants for the present study come from the Shanghai
Diabetes GWAS Study and from a nested case control study of
T2D identified from two prospective cohort studies the Shanghai
Women’s Health Study (SWHS) and the Shanghai Men’s Health
Study (SMHS).
The Shanghai Diabetes GWAS Study (SDGS). The SDGS
includes genome wide scan data of 1,019 diabetes cases and 1,710
controls. Details of the study design have been described elsewhere
[5]. Briefly, diabetes cases in the SDGS included 886 incident
T2D cases identified in the Shanghai Women’s Health Study
(SWHS), a population-based cohort study of 74,941 women [15]
and 133 prevalent T2D cases identified from female controls of the
Shanghai Breast Cancer Study (SBCS), a population-based case-
control study [16]. The 886 diabetes cases identified from the
SWHS all met the following criteria: (1) age #65 with a self-
reported diabetes diagnosed after study enrollment; (2) used
diabetes medication; (3) had fasting glucose level .7 mmol/L at
least twice, and (4) donated a blood sample. The 133 diabetes cases
identified from the controls of SBCS were women who were
diagnosed with T2D and were on diabetes medication or had
a blood glucose level .7 mmol/L (measured by study). The 1,710
controls used in this GWAS were shared with a GWAS of breast
cancer that was recently completed and was based primarily based
on the Shanghai Breast Cancer Study (SBCS). Excluded from the
control group are women who (1) had a self-reported history of
diabetes; or (2) had a blood glucose level between 5.5 and
7 mmol/L and had HbA1C .6.1% or had no HbA1C data.
The SWHS and the SMHS are both population-based,
prospective cohort studies based in urban Shanghai, China. The
SWHS began first and recruited 74,941 women aged 40–70 years
from 1997 to 2000 The SMHS recruited 61,491 men aged 40–74
years from 2002 to 2006 [17]. The validation sample includes 967
incident T2D cases and 913 controls from the SWHS [15] and
733 male incident T2D cases and 734 controls from the SMHS
[18].
Anthropometric measurements and exercise
participation. Body weight and height were measured in the
SWHS, the SMHS and SBCS using identical protocols. All
anthropometric measurements including weight, height, and
circumferences of waist and hips were taken twice during the in-
person interview according to a standard protocol by trained
interviewers who were retired medical professionals [19]. From
these measurements, the following variables were created: body
mass index (BMI), weight in kg divided by the square of height in
meters and waist-hip ratio (WHR), waist circumference divided by
hip circumference. Physical activity patterns were assessed during
the in-person interviews. Regular exercise and sports participation
were evaluated for the past 10 years in the SBCS and for the past 5
years in the SWHS and in the SMHS using validated ques-
tionnaires [20,21].
SNP Selection and Genotyping
The National Human Genome Resource Institute’s (NHGRI)
GWAS catalog [Accessed 10/12/2010] [22], was used to identify
single nucleotide polymorphisms (SNPs) previously associated with
high T2D. We selected 35 SNPs that had been associated with
T2D in recent GWAS studies (October 2011) that had a minor
allele frequency in Han Chinese (according to HAPMAP CHB
group) of at least 5%. The SNPs selected were BCL11A
(rs243021), RBMS1, ITGB6 (rs7593730), IRS1 (rs7578326,
rs2943641), ADAMTS9 (rs4607103), IGF2BP2 (rs4402960),
CDKAL1 (rs7756992, rs10440833), JAZF1 (rs864745), KLF14
(rs972283), TP53INP1 (rs896854), SLC30A8 (rs13266634),
CDKN2A, CDKN2B (rs10811661, rs564398), CDC123,
CAMK1D (rs12779790), HHEX, IDE (rs5015480, rs1111875),
KCNQ1 (rs2237892), KCNJ11 (rs5215), intergenic (rs9300039),
MTNR1B (rs1387153), HMGA2 (1531343), TSPAN8, LGRS
(rs7961581, rs4760790), C2CD4A, C2CD4B (rs7172432), FTO
(rs8050136, rs11642841), SRR (rs391300), HNF1B, TCF2
(rs4430796), DUSP9 (rs5945326), PTPRD (rs17584499),
CHCHD9 (rs13292136), CENTD2 (rs1552224), ZFAND6
(rs11634397). In addition, 4 SNPs identified in a meta-analysis
of the Asian consortium were also included: KCNK15
(rs3734618), SPRY2 (rs1215468), CMIP (rs12599890) and
FITM2-R3HDML-HNF4A (rs6017317).
Genotyping, for the SDGS study and
Imputation. Genotyping was performed using the Affymetrix
6.0 array. The Birdseed v2 algorithm (http://www.broad.mit.
edu/mpg/birdsuite/) was used to call genotypes. QC procedures
included removal of SNPs with MAFs,0.01, Hardy-Weinberg P-
values less than 0.00001, and samples with more than 5% missing
genotypes. There were 15 SNPs that had been genotyped and the
other SNPs that have been reported to be associated with T2D
that were not available were imputed using the program MACH
(http://www.sph.umich.edu/csg/abecasis/MACH/), using the
phased Asian data from HapMap Phase II (release 22) as the
reference. Only data with high imputation quality (RSQR.0.3 for
MACH) were included in the current analysis.
Genotyping for the nested case control
study. Genotyping for the 39 SNPs included in the SWHS
and SMHS sample set was completed using the iPLEX Sequenom
MassArray platform. Included in each 96-well plate as quality
control samples were two negative controls, two blinded duplicates
and two samples included in the HapMap project. There were 2
SNPs that failed analysis (rs231362 and rs1531343), and one SNP
was out of Hardy-Weinberg equilibrium HWE (P,1024);
(rs5945326) leaving a total of 36 SNPs for analysis.
Data analyses. A total of 74 participants with whom data on
four or more genotypes were missing were excluded from the
analysis leaving 6,001 participants for the analyses. Demographic
and lifestyle parameters were compared between cases controls
using Mann Whitney rank sum tests for age, as this variable is not
normally distributed, or ANOVA, for other continuous variables.
Chi-squared statistics were used to evaluate differences between
cases and controls for categorical variables. Single-marker
association analyses were carried out to the selected SNP
associations with T2D risk. Odds Ratios (ORs) and 95%
confidence intervals (CI) were estimated using logistic regression
models with adjustment for age, gender and BMI. The association
between genotype and T2D risk was evaluated based on an
additive genetic model, indexing exposure to risk allele reported in
literature. To determine our power to detect previously reported
effect sizes across a range of allelic frequencies, we used the
program PS, to model T2D as a categorical variable with a fixed
sample size under an additive model. [23]. To determine our
power to detect an effect, we used independent case-control
numbers with a ratio of 1.24, reflecting the control: case ratio
(3,322 controls to 2,679 cases). We tested our power to detect
association at an alpha of 0.05 (two-sided) under the additive
model and used using an uncorrected chi-square test.
Type 2 Diabetes Genetic Risk Score
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Genetic risk score. We calculated two risk scores, one with
all the SNPs (GRS1) and one with those SNPs that were
significantly associated with T2D in the present study (GRS2).
We assumed an additive genetic model for each SNP applying
a linear weighting of 0, 1 or 2 to genotypes containing 0, 1 or 2 risk
alleles respectively. We also calculated weighted GRS by
multiplying the GRS by a weighted factor, calculated as = (number
of risk alleles/risk alleles-missing genotypes). We checked the
Linkage disequilibrium among SNPs in the same loci to see if the
r2 was over 0.80 before calculating the GRSs and found this not
the case.
We evaluated the joint effect of the GRSs and obesity categories
according to the WHO recommendations [24], WHR categories
(tertiles) and exercise participation (yes/no). We also developed
a composite lifestyle high risk score by adding the number of risk
factors associated with higher risk of T2D: having high BMI,
(.25 kg/m2), having a high WHR (.0.85), and no exercise
participation. Multiplicative interactions between GRSs and BMI,
WHR or exercise participation were examined using the log
likelihood ratio test, which compared the model including only the
main effect with the model that included both the main effects and
the interactive terms. Interaction terms were coded as the product
of the genetic and environmental factors under investigation and
were considered residual effects after main effects for each SNP.
The unknown regression coefficient parameters were estimated
using maximum likelihood, conditional on the random variables
for genetic, environmental factors, and their products.
All analyses were performed using SAS (version 9.1). All P
values presented are based on two-tailed tests. P values presented
in this paper were not corrected for multiple testing.
Results
Associations of selected demographic characteristics and risk
factors with T2D are shown in Table 1. As expected, cases and
controls differed in regards to age, BMI, WHR, exercise
participation and combined high risk factor score. Table 2
presents the association of GWAS-identified, T2D-related SNPs
with T2D adjusted for BMI, age and sex in our study population.
Fourteen variants in twelve gene regions (IGF2BP2, CDKAL1,
KCNK15, TP53INP1, SLC30A8, CDKN2A/CDKN2B, CDC123/
CAMK1D, HHEX/IDE, KCNQ1, KCNJ11, SPRY2 and HNF1B/
TCF2) were significantly associated with T2D. All the SNPs that
were significantly associated with T2D in our study (P,0.05), had
a direction of association consistent with prior GWAS. Further, 23
of 36 SNPs associated with T2D by GWAS showed a consistent
direction of association (as indicated by OR) with T2D in our
study population (P= 0.066, binomial sign test).
According to our power calculations, we only had 88% power to
detect significance (P,0.05) for alleles with MAF of 0.26 (the
average MAF in this study) and ORs of 1.2 or greater. The
average OR for the 14 SNPs for which we detected significance
was 1.18.
We calculated two risk scores, GRS1, based on all thirty six
SNPs in unique loci, and GRS2, based on the fourteen SNPs
significantly associated with T2D. Risk alleles were defined by
previously reported T2D GWAS results for all variants included in
GRS1 and GRS2. The associations of GRS1 and GRS2 with T2D
were evaluated by logistic regression. Both, GRS1, (OR=1.08;
95% CI: 1.06–1.09) and GRS2 (OR=1.15; 95% CI: 1.13–1.18),
were significantly associated with a higher risk of T2D in analysis
adjusted for age, sex and BMI. The OR for quintiles of the GRS1
were 1.00, 1.26, 1.69, 1.95 and 2.18 (P,0.0001) and 1.00, 1.33,
1.60, 2.03 and 2.80 (P,0.001) for GRS2 (Table 3).
The joint effect of BMI categories, WHR categories, and
exercise participation, with GRS1 tertiles on T2D was evaluated
(Table 4). We found that individuals in the highest categories of
GRS1 and categories of BMI (,=or .25 kg/m2), WHR (,=or
.0.85), and no exercise participation, WHR or who had no
exercise participation had the highest ORs for risk of T2D
compared with those in the lowest categories or GRS1, low BMI,
low WHR or participating in exercise. The P value for interaction
was only significant for association between GRS1 and WHR.
Participants in the highest tertiles of both GRS1 and higher
number of risk factors were more likely to have T2D than controls
(OR=13.06, 95% CI= 8.65–19.72) compared with participants
with no risk factor and lower GRS1 category. The P value for the
multiplicative interaction factor was of marginal significance.
Table 5 shows joint effects between BMI, WHR, exercise
participation and lifestyle combined risk factors with GRS2
(tertiles). We found similar results than those with GRS1 and
lifestyle factors, with the joint association between GRS2 and
lifestyle factors being stronger although the P values for interaction
failed to reach significance.
Discussion
In this study we systematically evaluated the combined effects of
a genetic risk score and a lifestyle risk score with T2D risk.
Participants with a high GRS and high BMI, high WHR, no
exercise participation or of a combination of these high risk factors
were at increased risk of developing T2D. We only observed and
statistically significant P value for interaction between WHR and
GRS1.
Some data is available on GRS and T2D risk in European
ancestry populations. In a large nested case-control study of 2,809
Table 1. Characteristics of the study population.
Controls Cases P value
Age (yrs) Median 53.16 58.57 ,.0001
BMI (mean) 23.7 26.4 ,.0001
WHR (mean) 0.83 0.87 ,.0001
Men (%) 21.46 26.76 ,.0001
BMI categories (%)
,=25 68.4 36.4 ,0.001
.25–,30 27.3 49.3
.=30 4.3 14.3
WHR terciles (%)
T1 42.9 18.9 0.001
T2 30.5 32.8
T3 26.6 48.3
PA (%) 0.07
No exercise 63.6 61.3
Exercise 36.4 38.7
Combined Risk factors
0 17.0 7.6 0.001
1 47.8 26.7
2 25.6 41.7
3 9.6 24.0
1P-value for comparison of using Wilcoxon Two-sample Tests. For comparison
of categorical variables a x2-square test was used.
doi:10.1371/journal.pone.0049464.t001
Type 2 Diabetes Genetic Risk Score
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T2D cases and 3,501 controls from the Health Professionals
Follow-up Study and Nurses’ Health Study (all of European
ancestry), a. GRS was calculated with 10 SNPs in 9 loci. The odds
ratio for T2D with each point of GRS, corresponding to 1 risk
allele, was 1.19 (95% CI, 1.14–1.24) for men and 1.16 (CI, 1.12 to
1.20) for women, (12). In a recent study involving an African
American population, the trend of increase in risk for T2D with
increasing risk allele load was similar to observations in European-
derived populations [9]. Some studies have been conducted in
Asian populations and have reported similar results. For example
the per-allele odds ratio for the development of T2D was 1.12
(95% CI: 1.00–1.25; P= .049) in a Japanese study [10]. In another
study conducted in Pakistani population (from the UK and from
Pakistan), the GRS using 30 T2D associated SNPs was also
associated with a higher risk of T2D [25].
Two studies in China have evaluated associations between
genetic risk scores and T2D. In one of the studies, 19 GWAS
SNPS were validated using data from two community based
studies, a case control study with subjects with T2D, impaired
glucose tolerance and normal glucose and data from a prospective
study of 734 non diabetic and 67 T2D incident cases [26]. A GRS
was calculated using 4 SNPs in the following loci (CDKAL1,
Table 2. Association of GWAS-Identified T2D-Related SNPs with T2D Risk.
Locus rsID Nearby Gene Effect allele{ Other allele
effect allele
freq OR (95% CI){{ P value GRS2*
1 rs243021 BCL11A A G 0.68 1.03(0.95–1.12) 0.47
2 rs7593730 RBMS1, ITGB6 C T 0.83 1.03(0.93–1.15) 0.56
3 rs7578326 IRS1 A G 0.85 0.99(0.88–1.12) 0.87
4 rs2943641 IRS1 C T 0.93 1.08(0.93–1.26) 0.33
5 rs4607103 ADAMTS9 C T 0.63 0.98(0.90–1.06) 0.57
6 rs4402960 IGF2BP2 T G 0.25 1.19(1.09–1.30 0.0002 Y
7 rs7756992 CDKAL1 G A 0.52 1.16(1.07–1.26) 0.0002 Y
8 rs10440833 CDKAL1 A T 0.40 1.27(1.17–1.38) ,0.0001 Y
9 rs3734618 KCNK15 A G 0.45 1.10(1.02–1.19) 0.02 Y
10 rs864745 JAZF1 T C 0.77 0.96(0.88–1.06) 0.44
11 rs972283 KLF14 G A 0.72 1.09(1.00–1.19) 0.06
12 rs896854 TP53INP1 T C 0.32 1.16(1.06–1.26) 0.0007 Y
13 rs13266634 SLC30A8 C T 0.59 1.09(1.01–1.19) 0.03 Y
14 rs17584499 PTPRD T C 0.10 1.13(0.97–1.32) 0.12
15 rs564398 CDKN2A, CDKN2B T C 0.88 1.06(0.94–1.20) 0.35
16 rs10811661 CDKN2A,CDKN2B T C 0.54 1.20(1.11–1.30) ,0.0001 Y
17 rs13292136 CHCHD9 C T 0.90 0.99(0.87–1.13) 0.93
18 rs12779790 CDC123,CAMK1D G A 0.17 1.11(1.00–1.24) 0.05 Y
19 rs1111875 HHEX,IDE C T 0.30 1.22(1.12–1.33) ,0.0001 Y
20 rs5015480 HHEX,IDE C T 0.17 1.34(1.21–1.49) ,0.0001 Y
21 rs2237892 KCNQ1 C T 0.67 1.20(1.10–1.31) ,0.0001 Y
22 rs5215 KCNJ11 T C 0.40 1.15(1.06–1.24) 0.0008 Y
23 rs9300039 Intergenic C A 0.75 1.07(0.97–1.17) 0.18
24 rs1552224 CENTD2 A C 0.92 1.08(0.94–1.25) 0.26
25 rs1387153 MTNR1B T C 0.42 0.99(0.91–1.07 0.72
26 rs4760790 TSPAN8,LGR5 A G 0.24 0.99(0.90–1.09) 0.84
27 rs7961581 TSPAN8,LGR5 C T 0.21 0.99(0.90–1.09) 0.84
28 rs1215468 SPRY2 A G 0.72 1.27(1.16–1.38) ,0.001 Y
29 rs7172432 C2CD4A,C2CD4B G A 0.39 0.96(0.88–1.04) 0.27
30 rs11634397 ZFAND6 G A 0.09 0.92(0.80–1.05) 0.21
31 rs8050136 FTO A C 0.12 1.08(0.96–1.22) 0.22
32 rs11642841 FTO A C 0.04 1.00(0.81–1.23) 1.00
33 rs12599890 CMIP T C 0.72 0.94(0.87–1.08) 0.14
34 rs391300 SRR C T 0.71 0.99(0.91–1.02) 0.85
35 rs4430796 HNF1B,TCF2 G A 0.30 1.18(1.05–1.31) 0.004 Y
36 rs6017317 FITM2-R3HDML-HNF4A G T 0.43 1.08(1.00–1.17) 0.06
T2D increasing risk allele identified in prior GWAS study.
{{ORs and 95% confidence intervals for association with T2D, adjusted for age, sex and BMI.
*SNP is used in the calculation of the GRS2 genetic risk score (see Methods).
doi:10.1371/journal.pone.0049464.t002
Type 2 Diabetes Genetic Risk Score
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SLC30A8, CDKN2A/CDKN2B an, KCNQ1). The OR for the case
control study (comparing T2D with normal glucose tolerance was
1.28 (1.21–1.35) and that comparing GRS in impaired glucose
tolerance with normal glucose tolerance was 1.18 (1.11–1.25). In
the prospective study the GRS OR was 1.33 (1.08–1.68). Another
cross-sectional study conducted in China of 3,210 participants
calculated a GRS using 17 GWAS confirmed SNPs and the odds
ratio for T2D (per risk allele) was 1.18 (95% CI 1.12–1.23,
p,0.0001) [13], which is similar to what we found in our study
and they found a multiplicative interactive effect between BMI
with fasting glucose and HbA1c but not with T2D. No joint effect
with physical activity and the GRS score was found with T2D or
fasting glucose.
In our study no statistically significant interactions were
observed between the GRS1 and GRS2 and BMI, exercise
participation and combined risk factors. Participants with a high
GRS1 and GRS2 and high BMI, no exercise participation, high
WHR of a combination of high risk factors were at substantially
increased risk of developing T2D compared with those with lower
GRS and lower lifestyle risks factors (alone or in combination).
These findings suggest the potential value of using genetic markers
to identify populations at high risk for T2D for targeted
prevention. An interaction between WHR and the GRS1 was
found. Our results are in agreement with a recent publication from
a prevention trial. In an updated GRS using 34 T2D associated
loci, in the Diabetes Prevention Program (DPP) conducted in the
U.S. population, the ability of the score to predict diabetes
incidence or regression to normal glucose tolerance was tested,
and a high GRS was associated with increased risk of developing
T2D and lower probability of returning to normal glucose
Table 3. Association between the genetic risk scores and
T2D*.
GRS1 GRS2
OR (95% CI) P value OR(95% CI) P value
Quintiles
Q1 1.00 1.00
Q2 1.26 (1.07–1.50) 1.33 (1.12–1.58)
Q3 1.69 (1.39–2.05) 1.60 (1.32–1.94)
Q4 1.95 (1.64–2.33) 2.03 (1.69–2.44)
Q5 2.18 (1.81–2.62) 2.80 (2.35–3.35)
,0.0001 ,0.0001
Continuous 1.08 (1.06–1.09) ,0.0001 1.15 (1.13–1.18) ,0.0001
*Adjusted for age, sex and BMI.
doi:10.1371/journal.pone.0049464.t003
Table 4. Joint Effects of BMI, WHR, exercise participation and combined lifestyle risk factor with GRS1categories on T2D.
Genetic Risk Score Terciles
,=34 .34–37.21 .37.21
BMI* OR 95% CI OR 95% CI OR 95% CI
,= 25 1.00 1.54 1.27–1.87 1.87 1.55–2.26
25–,30 3.49 2.86–4.26 4.64 3.76–5.73 5.79 4.71–7.13
.= 30 6.70 4.81–9.32 8.59 5.88–12.55 11.08 7.39–16.62
Pinteraction 0.85
WHR* OR 95% CI OR 95% CI OR 95% CI
Low(T1) 1.00 1.37 1.05–1.79 2.05 1.59–2.65
Medium (T2) 2.37 1.84–3.06 4.01 3.11–5.19 3.83 2.98–4.92
High (T3) 5.29 4.10–6.83 6.51 4.99–8.49 7.93 6.10–10.32
Pinteraction 0.04
PA** OR 95% CI OR 95% CI OR 95% CI
Yes 1.00 1.44 1.15–1.80 1.91 1.53–2.37
No exercise 1.27 1.04–1.55 1.82 1.48–2.23 2.22 1.81–2.72
Pinteraction 0.79
Combined Factors* OR 95% CI OR 95% CI OR 95% CI
none 1.00 1.84 1.19–2.85 2.65 1.75–4.01
One 1.94 1.34–2.80 2.62 1.82–3.78 3.08 2.14–4.43
Two 4.88 3.39–7.01 8.03 5.54–11.65 9.53 6.59–13.78
Three 10.73 7.19–16.02 11.16 7.35–16.93 13.06 8.65–19.72
Pinteraction 0.06
*Adjusted for age and sex.
**Adjusted for age, sex and BMI.
+The log-likelihood ratio test was used to test the interaction effect of GRS with other risk factors on T2D risk.
doi:10.1371/journal.pone.0049464.t004
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tolerance state in high-risk individuals. They found that a lifestyle
intervention attenuates this risk [14].
A strength of this study is that we have included a large number
of SNPs identified from NHGRI GWAS catalog. A limitation of
the study is that most of the SNPs have been identified from non-
Asian populations. Other strengths include that this is a popula-
tion-based epidemiological study that has comprehensively eval-
uated GWAS-identified T2D markers in association with T2D risk
and interactions with modifiable risk factors of T2D including
physical activity levels and a combination of risk factors. The vast
majority of our study population is of a single ethnicity, reducing
the potential effects of population stratification. The relatively
large sample size and the detailed exposure information allowed us
to evaluate the joint effect of T2D-related genetic markers and
lifestyle risk factors on T2D risk.
Our study has some limitations. The linear models we used for
the analysis have reduced power for detecting interactions and this
might partially explain the marginal significance of the interactions
found in this study. Larger independent studies will be needed to
conclusively demonstrate whether the models we have identified
here are true examples of effect modification. In addition the SNPs
used to construct the GRS do not include many SNPs identified by
GWAS studies in Chinese populations. When we did our SNP
selection from the GWAS catalogue the majority of the studies had
been conducted in white populations. We included SNPs from one
study [27] that was published at the time. Other studies have been
published since then, including a meta-analysis conducted in East
Asian populations [28].
Another limitation is that the study subjects come from different
studies and thus it is possible that the heterogeneous study
population may have introduced bias in the association tests.
In summary, our study found associations between the GRS
and T2D risk. We also found that a joint effect between genetic
and modifiable risk factors although the interaction test failed to
reach significance. The GRS provides a measure of the combined
genetic effect of T2D associated loci.
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Table 5. Joint Effects of BMI, WHR, exercise participation and combined lifestyle risk factor with GRS2 categories on T2D.
Genetic Risk Score Terciles
,=9 .9–11.43 .11.43
BMI* OR 95% CI OR 95% CI OR 95% CI
,= 25 1.00 1.67 1.37–2.05 2.72 2.34–3.30
25–,30 3.88 3.08–4.70 5.37 4.33–6.65 7.76 6.25–9.63
.= 30 7.97 5.58–11.38 8.88 6.19–12.75 14.74 9.84–22.07
P interaction 0.23
WHR* OR 95% CI OR 95% CI OR 95% CI
Low(T1) 1.00 1.28 0.97–1.68 3.05 2.35–3.96
Medium (T2) 2.59 1.99–3.38 4.09 3.17–5.29 4.77 3.69–6.17
High (T3) 5.12 3.93–6.67 7.48 5.72–9.78 10.14 7.76–13.24
P interaction 0.0003
PA** OR 95% CI OR 95% CI OR 95% CI
Yes 1.00 1.54 1.22–1.93 2.41 1.93–3.02
No exercise 1.25 1.01–1.54 1.86 1.51–2.29 3.04 2.46–3.75
P interaction 0.96
Combined Factors* OR 95% CI OR 95% CI OR 95% CI
none 1.00 1.94 1.24–3.05 3.48 2.25–5.39
One 1.93 1.30–2.86 2.58 1.75–3.81 4.57 3.11–6.71
Two 5.21 3.53–7.69 8.91 6.02–13.19 11.70 7.91–17.30
Three 10.65 6.95–16.32 12.63 8.22–19.40 18.13 11.72–28.04
P interaction 0.10
*Adjusted for age and sex.
**Adjusted for age, sex and BMI.
+The log-likelihood ratio test was used to test the interaction effect of GRS with other risk factors on T2D risk.
doi:10.1371/journal.pone.0049464.t005
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